-Jer-Tsong Hsieh Researcher Activity Profile

Research Author Detailed Information 

Jer-Tsong Hsieh Publication Rate By Year

Jer-Tsong Hsieh has published 1 paper(s) in 1990, 2 paper(s) in 2006, 13 paper(s) in 2007, 5 paper(s) in 2008, for a total of 21 research publications in total.

Jer-Tsong Jt Hsieh Author Information

LAST NAME: hsieh

FIRST NAME: Jer-Tsong

INITIALS: jt

AFFILIATION:

Papers

Jer-Tsong Hsieh's Publication Record

1. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application. Year Published: 2006
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA.
2. Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy. Year Published: 2006
Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
3. Elevated plasma factor VIII coagulant activity presenting with thrombophlebitis of the deep dorsal vein of the penis. Year Published: 2007
Department of Urology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan 100.
4. Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses. Year Published: 2007
James Buchanan Brady Urology Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-2101, USA.
5. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Year Published: 2007
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
6. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. Year Published: 2007
Department of Urology, The University of Texas, Southwestern Medical Center, Dallas Texas, 75390-9110, USA.
7. Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. Year Published: 2007
Department of Urology, NYU Cancer Institute, New York University School of Medicine, New York, NY 10016, USA.
8. Genetic and biologic evidence that implicates a gene in aggressive prostate cancer. Year Published: 2007
9. Elevated plasma factor VIII coagulant activity presenting with thrombophlebitis of the deep dorsal vein of the penis. Year Published: 2007
Department of Urology, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan 100.
10. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. Year Published: 2007
Department of Urology, The University of Texas, Southwestern Medical Center, Dallas Texas, 75390-9110, USA.
11. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Year Published: 2007
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX.
12. Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome. Year Published: 2007
Department of Urology, NYU Cancer Institute, New York University School of Medicine, New York, NY 10016, USA.
13. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Year Published: 2007
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9039, USA.
14. Genetic and biologic evidence that implicates a gene in aggressive prostate cancer. Year Published: 2007
15. Correcting penoscrotal web with the v-y advancement technique. Year Published: 2008
Department of Urology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taiwan.
16. Selective prostate cancer thermal ablation with laser activated gold nanoshells. Year Published: 2008
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
17. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Year Published: 2007
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9039, USA.
18. Selective prostate cancer thermal ablation with laser activated gold nanoshells. Year Published: 2008
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
19. Urethral prolapse in female children: report of two cases. Year Published: 1990
20. Correcting penoscrotal web with the V-Y advancement technique. Year Published: 2008
21. Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer. Year Published: 2008
Authors' Affiliations: Departments of Urology, Radiology, and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas and Department of Urology, The First Hospital of Xi'an Jiaotong University, Xi'an, China.